M. Beier

发表

Association between risperidone treatment and cerebrovascular adverse events: examining the evidence and postulating hypotheses for an underlying mechanism.

David A. Smith, M. Beier, 2004, Journal of the American Medical Directors Association.

Drug treatment for Alzheimer's disease. Commentary: Memantine treatment in patients with moderate-to-severe Alzheimer's disease already receiving donepezil: a randomized controlled trial.

M. Beier, 2004, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.

Updated 2012 Beers Criteria: what's noteworthy and cautionary?

M. Beier, 2012, Journal of the American Medical Directors Association.

ASCP's 2021 Choosing Wisely® Recommendations: A Proud Accomplishment.

M. Beier, M. Brodeur, 2022, The Senior care pharmacist.

Warfarin monitoring woes: a glimmer of hope with pharmacogenomics.

M. Beier, 2008, Journal of the American Medical Directors Association.

Gradual dose reduction and medication tapering: a clinical perspective.

Caren McHenry Martin, M. Beier, C. Martin, 2007, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.

Pharmacokinetic interaction and erythromycin-induced sudden cardiac death: implications for practice.

M. Beier, 2005, Journal of the American Medical Directors Association.

Alzheimer ’ s Disease Treatments Under Investigation and Their Respective Therapeutic Targets AD Pathophysiologic Mechanism as Therapeutic Target Drug Treatment Neurotransmission Cholinesterase inhibitors Excitotoxicity Memantine Oxidative stress Ginkgo biloba

M. Beier, 2022 .

Harmless herbs? Think again: merits of a complete medication history.

M. Beier, 2006, Journal of the American Medical Directors Association.

Management of Urinary tract infections in the nursing home elderly: a proposed algorithmic approach.

M. Beier, 1999, International journal of antimicrobial agents.

Pharmacogenetics: has the time come for pharmacists to embrace and implement the science?

M. Beier, Madhumitha Panchapagesan, Ladd E Carman, 2013, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.

The serotonin syndrome revisited.

M. Beier, 2005, Journal of the American Medical Directors Association.

ALZHEIMER'S DISEASE: CHALLENGES FOR THE PATIENT'S FAMILY

M. Beier, 2005 .

Treatment Strategies for the Behavioral Symptoms of Alzheimer's Disease: Focus on Early Pharmacologic Intervention

M. Beier, 2007, Pharmacotherapy.

ALZHEIMER'S DISEASE: EPIDEMIOLOGY AND RISK FACTORS

M. Beier, 2005 .

Pharmacotherapy of behavioral and psychological symptoms of dementia: a review of atypical antipsychotics.

L. Daiello, V. P. Hoffmann, M. Beier, 2003, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.

Pharmacotherapy for behavioral and psychological symptoms of dementia in the elderly.

M. Beier, 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

ALZHEIMER'S DISEASE: A CLINICAL OVERVIEW

M. Beier, 2007 .

Drug treatment for Alzheimer's disease. Commentary: Memantine treatment in patients with moderate-to-severe Alzheimer's disease already receiving donepezil: a randomized controlled trial.

M. Beier, 2004, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.

The Effect of Pharmacist-Initiated Deprescribing Interventions in Older People: A Narrative Review of Randomized Controlled Trials.

M. Beier, Michelle Nguyen, Diana N Louden, 2023, The Senior care pharmacist.